News

Throughout May, the NICHD highlighted important information about women’s health, particularly women’s health research. These efforts coincided in part with National Women’s Health Week, from May 11 to 17.

Lisa M. Halvorson, M.D., has been named the new Chief of the Gynecologic Health and Disease Branch (GHDB), effective June 15, 2014, announced Dr. Catherine Spong, M.D., Director of the Division of Extramural Research.

The NICHD spent the last month highlighting important information about infertility.

Conversation between Rebecca Lazeration and three NICHD researchers who are working to advance the field of reproduction science.

Check out our infographic to learn the facts, and share it to spread the word.

A variant in a gene active in cells of the ovary may lead to the overproduction of androgens—male hormones similar to testosterone— occurring in women with polycystic ovary syndrome (PCOS), according to scientists funded by the National Institutes of Health. The discovery may provide information to develop a test to diagnose women at risk for PCOS and also for the development of a treatment for the condition.

This month’s NICHD Research Perspectives podcast focuses on adrenal gland disorders and research conducted by NICHD staff at the NIH Clinical Center.

On December 5, 2012, the NICHD released the Scientific Vision: The Next Decade, the culmination of a collaborative process that began in 2011 to identify the most promising scientific opportunities for the Institute and the research community to pursue over the next decade. The Vision statement was made available during the NICHD’s 50th anniversary colloquium.

​Alan Guttmacher, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announced a number of changes to streamline the institute’s organizational structure and accelerate the exchange of scientific ideas.

A document charting a research course for the many collaborators who share an interest in promoting the science concerning human development through the life span, child health, women's health, and rehabilitation research is now available online.

As the Institute marks its golden anniversary, we look back on the NICHD's early years, its scientific accomplishments, and its future.

PCOS is the most common cause of anovulatory infertility (related to the absence of ovulation), affecting an estimated 100 million women of childbearing age worldwide, and about 5 million women of childbearing age in the United States.

The June 2012 NICHD Research Perspectives—NICHD' monthly podcast series—features discussions of a treatment that reduces the body temperatures of infants who experience oxygen deficiency at birth, the effectiveness of progesterone as a treatment for the infertility associated with polycystic ovary syndrome, and the influence that engaging the attention of young children with autism has on their language development.

According to the Centers for Disease Control and Prevention (CDC), infertility affects about 12% of all people of reproductive age—women and men—in the United States attempting to get pregnant. Other estimates suggest that the numbers are even higher

The hormone progestin, often given as a first step in infertility treatment for polycystic ovary syndrome (PCOS), appears to decrease the odds of conception and of giving birth, according to a study by a National Institutes of Health research network.

More than two-thirds of U.S. adults are overweight or obese, and approximately 17% of Americans ages 2 to 19 are overweight or obese, according to the Centers for Disease Control and Prevention (CDC). Obesity increases the likelihood of many serious health problems, including heart disease, high blood pressure, type 2 diabetes, stroke, certain cancers, fatty liver disease, cirrhosis, liver failure, pregnancy complications, and infertility. Being overweight can be emotionally painful and can significantly impact life expectancy.

Young women in the Washington, D.C., area who have polycystic ovarian syndrome (PCOS) are encouraged to take part in a study at the National Institutes of Health on the possible role of the adrenal glands in the disorder.

Millions of Americans with reproductive health disorders stand to benefit from new research funded by the National Institutes of Health. With funds from the American Recovery and Reinvestment Act, the National Institutes of Health today announced grants totaling nearly $60 million for research into disorders that impair fertility, cut short a woman's reproductive years, and often cause intense pain.

NIH-sponsored researchers have discovered that women who have polycystic ovary syndrome (PCOS) are less likely to ovulate in response to a promising new drug treatment for the condition if they have a variation in a particular gene.

Metformin, a drug used to treat diabetes and thought to hold great promise at overcoming the infertility associated with polycystic ovary syndrome (PCOS), is less useful for helping women with the condition achieve pregnancy than is the standard treatment with the infertility drug clomiphene, report researchers in an NIH research network.